Form 4 for ACET Adicet Bio, Inc.
Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-07 · accession 0001209191-22-056193 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-11-09 | 2022-11-07 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $19.05 | -30.0K | 83.4K | -26% | -$571.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-07 | S | D | 30,000 | $19.05 | 83,424 | I See Footnote | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $19.00 to $19.24, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request. (F3) Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee. |